Showing results (131-140 of 6,005) with videos related to

Sort By:
Pageof 601
Molecular Cancer Therapeutics|December 6, 2015
Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10-Dependent Apoptosis by Carfilzomib and SelinexorShaun Rosebeck, Mattina M Alonge, Malathi Kandarpa, et al.
Molecular Cancer Therapeutics|December 6, 2015
AT2R Gene Delivered by Condensed Polylysine Complexes Attenuates Lewis Lung Carcinoma after Intravenous Injection or Intratracheal SprayNabil A Alhakamy, Susumu Ishiguro, Deepthi Uppalapati, et al.
Molecular Cancer Therapeutics|February 18, 2016
Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung CancerJi-Young Jang, Yong-Goo Kim, Soo Jeong Nam, et al.
Molecular Cancer Therapeutics|October 22, 2017
Overcoming Resistance to Cetuximab with Honokiol, A Small-Molecule PolyphenolHannah E Pearson, Mari Iida, Rachel A Orbuch, et al.
Molecular Cancer Therapeutics|October 22, 2017
Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1)Matthew Sung, Xingzhi Tan, Bingwen Lu, et al.
Molecular Cancer Therapeutics|October 22, 2017
Theranostic Radiolabeled Anti-CD20 sdAb for Targeted Radionuclide Therapy of Non-Hodgkin LymphomaAhmet Krasniqi, Matthias D'Huyvetter, Catarina Xavier, et al.
Molecular Cancer Therapeutics|July 25, 2022
Comparative Oncology Assessment of a Novel Inhibitor of Valosin-Containing Protein in Tumor-Bearing DogsAmy K LeBlanc, Christina N Mazcko, Timothy M Fan, et al.
Molecular Cancer Therapeutics|May 2, 2022
Luxeptinib (CG-806) Targets FLT3 and Clusters of Kinases Operative in Acute Myeloid LeukemiaWilliam G Rice, Stephen B Howell, Hongying Zhang, et al.
Molecular Cancer Therapeutics|May 2, 2022
Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial TumorsAlexandra L Martin, Carmen M Anadon, Subir Biswas, et al.
Molecular Cancer Therapeutics|June 22, 2018
KDM6B Counteracts EZH2-Mediated Suppression of IGFBP5 to Confer Resistance to PI3K/AKT Inhibitor Treatment in Breast CancerWenyu Wang, Keng Gat Lim, Min Feng, et al.
Pageof 601